ClinicalTrials.Veeva

Menu

Dairy and Inflammation Study (DRIVE)

Y

York University

Status

Completed

Conditions

Inflammation
Overweight and Obesity
Cardiometabolic Risk

Treatments

Other: Dairy Foods (Yoghurt, Cheese, Milk)

Study type

Interventional

Funder types

Other

Identifiers

NCT04902417
2021-177

Details and patient eligibility

About

The purpose of this study is to determine whether 6-weeks of increased dairy consumption can reduce inflammation and other markers of chronic disease while fasted or following a high-fat meal.

Full description

Following the acquisition of informed consent, eligibility to participate in the study will be determined using questionnaires, and certain parameters determined from a finger-prick blood sample. Eligible participants will be assigned to complete two 6-week dietary interventions in random order, with at least a 4 week "wash out" period (i.e. their habitual eating) in between. The two dietary interventions are: 1) Participants normal, low-dairy diet; and 2) A higher dairy diet where 3 servings per day of dairy foods are provided. Prior to beginning either 6-week diet intervention, participants will be asked to attend the laboratory at York University after an overnight fast to undergo baseline testing.

Following baseline testing, participants will meet with a registered dietitian (RD) to discuss each diet arm. Specifically, if they are on the dairy diet, participants will receive advice on how to incorporate these dairy foods into their diet by replacing other foods of similar energy content so as to not increase their total energy intake and body weight. They will meet with the RD at several other times throughout the study. During each 6-week diet period, they will be asked to keep their physical activity levels constant and to not adopt any other major dietary changes during the study.

At the end of each 6-week intervention period, participants will be asked to return to York University to repeat the initial set of tests performed at baseline. In addition to the fasted tests, a number of tests will be performed after asking participants to consume a high-fat test meal (i.e. a fast-food breakfast). Various measurements will continue to be taken for around 6 hours after this meal is consumed.

Enrollment

32 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Body mass index (BMI) ≥ 25 kg/m2

  • ≤ 2 structured exercise sessions/week

  • Habitual low dairy consumption (≤ 1 serving/day)

  • Having at least two other metabolic risk factors based on clinical guidelines:

    • Elevated blood pressure (≥130/≥85 mm Hg)
    • Impaired fasting glucose (≥5.6 mmol/L) measured using a finger prick sample
    • Impaired fasting triglycerides (≥1.7 mmol/L) or high-density lipoprotein (<1.03 mmol/L for males, <1.3 mmol/L for females) measured using a finger prick blood sample.
    • Increased waist circumference (≥102 cm for males and ≥88 cm for females).
    • Borderline high fasting low-density lipoprotein (≥3.5 mmol/L) or total cholesterol (≥5.2 mmol/L).

Exclusion criteria

  • Allergy to dairy foods, diagnosed lactose intolerance or an aversion to foods provided during the study
  • Previous history of diabetes and/or related cardiovascular disease
  • The use of multiple medications for managing lipids, glucose and/or blood pressure

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

32 participants in 2 patient groups

Low Dairy Habitual Diet
No Intervention group
Description:
Participants will follow their usual diet for 6-weeks, which includes low dairy consumption as screened for with the inclusion criteria.
High Dairy Diet
Experimental group
Description:
Participants will be provided with 3 servings of dairy per day to replace other foods within their diet (preventing weight gain over the intervention period) for 6-weeks
Treatment:
Other: Dairy Foods (Yoghurt, Cheese, Milk)

Trial contacts and locations

1

Loading...

Central trial contact

Joel Prowting, MSc; Andrea R Josse, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems